文献速递衰弱、肌少症与跌倒老年慢病共病管理

线粒体功能障碍与衰弱及肌少症的遗传证据:多组学孟德尔随机化与共定位研究

From mitochondrial dysfunction to frailty and sarcopenia: genetic evidence from multi-omics data via Mendelian randomization and colocalization.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2025-01-01

该研究采用基于汇总数据的孟德尔随机化与共定位分析,整合DNA甲基化、基因表达和血浆蛋白数量性状位点数据,覆盖1136个线粒体相关基因,评估其与衰弱指数及肌少症相关性状的因果关联。研究发现GRPEL1、LRPPRC、GATM、ETFDH等基因存在组织特异性因果关联,并识别出从甲基化到表达再到表型的完整调控通路,为年龄相关功能衰退提供了潜在治疗靶点。

要点

  • GRPEL1在血液中甲基化和表达水平与衰弱呈保护性关联,在脑/肌肉中呈不利关联。
  • LRPPRC在多种组织中一致显示对衰弱的保护效应,共定位证据强(PPH4 > 0.93)。
  • GATM与四肢瘦体重在全组学水平相关,血液中为负向、肌肉中为正向组织效应。

核心结论

  • 研究识别出衰弱与肌少症各自不同的线粒体遗传特征,关键基因包括GRPEL1、LRPPRC、GATM、ETFDH等,呈现组织特异性因果关联。
  • GRPEL1和GATM的完整调控通路被识别,连接甲基化、基因表达与表型。

研究设计与样本

  • 采用基于汇总数据的孟德尔随机化(SMR)分析,使用衰弱指数和肌少症相关性状的全基因组关联研究汇总统计量。
  • 分析DNA甲基化、基因表达和血浆蛋白丰度的数量性状位点数据,覆盖1136个线粒体相关基因,并用共定位分析确认共享因果变异。

主要发现

  • 对于衰弱,GRPEL1在甲基化和表达水平显示组织特异性关联:血液中保护(β = -.15,FDR = 1.5e-02),脑/肌肉中不利;LRPPRC跨组织一致保护(β = -.05至-.13,PPH4 > 0.93)。
  • 对于肌少症相关性状,GATM与四肢瘦体重(ALM)在所有组学水平相关,组织效应相反:血液中负向(β = -.03,FDR = 1.9e-09),肌肉中正向;ETFDH与ALM正相关(β = .03,FDR = 1.4e-06)。
  • 其他基因包括衰弱相关的CPS1和MMAB、握力相关的NTHL1和MTCH2、步速相关的TOMM70、BNIP3、TUFM。

关键数值与推荐

  • GRPEL1血液甲基化/表达与衰弱:β = -.15,FDR = 1.5e-02(保护);脑/肌肉中不利。
  • LRPPRC与衰弱:β = -.05至-.13,PPH4 > 0.93(保护)。
  • GATM与ALM:血液β = -.03,FDR = 1.9e-09(负向);肌肉正向。
  • ETFDH与ALM:β = .03,FDR = 1.4e-06(正向)。

临床怎么用

  • 这些线粒体相关基因可作为衰弱和肌少症风险评估的潜在生物标志物,但需进一步临床验证。
  • 组织特异性效应提示干预需考虑靶组织,血液标志物与外周组织效应可能不一致。
  • 识别出的调控通路为开发针对线粒体功能的治疗靶点提供了依据。

局限性

  • 研究基于遗传学推断的因果关联,未在干预性临床试验中验证。
  • 原文未报告样本量、人群特征及具体阈值,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Frailty and sarcopenia are age-related conditions linked to mitochondrial dysfunction, but their causal mechanisms remain poorly defined. This study aimed to identify mitochondrial-related genes causally associated with frailty and sarcopenia using comprehensive multi-omics approaches. We performed summary-data-based Mendelian randomization using genome-wide association study summary statistics for the frailty index and sarcopenia-related traits. Quantitative trait loci data for DNA methylation, gene expression, and plasma protein abundance were analyzed across 1136 mitochondrial-related genes. Colocalization analysis was applied to confirm shared causal variants. For frailty, GRPEL1 showed tissue-specific associations at methylation and expression levels (protective in blood: β = -.15, false discovery rate (FDR) = 1.5e-02; adverse in brain/muscle), while LRPPRC demonstrated consistent protective effects across tissues (β = -.05 to -.13, PPH4 > 0.93). For sarcopenia-related traits, GATM was associated with appendicular lean mass (ALM) across all omics levels with opposing tissue effects (negative in blood: β = -.03, FDR = 1.9e-09; positive in muscle), and ETFDH showed positive associations with ALM (β = .03, FDR = 1.4e-06). Additional genes included CPS1 and MMAB for frailty, NTHL1 and MTCH2 for grip strength, and TOMM70, BNIP3, TUFM for walking pace. Complete regulatory pathways were identified for GRPEL1 and GATM, linking methylation to expression to phenotype. This multi-omics study identified distinct mitochondrial genetic signatures for frailty and sarcopenia, with key genes including GRPEL1, LRPPRC, GATM, ETFDH, and others showing tissue-specific causal associations. These findings advance understanding of mitochondrial mechanisms in age-related functional decline and identify multiple therapeutic targets.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Wupuer A, Peng X, Wang J, et al. From mitochondrial dysfunction to frailty and sarcopenia: genetic evidence from multi-omics data via Mendelian randomization and colocalization. J Gerontol A Biol Sci Med Sci. 2025. PMID: 41129298. doi:10.1093/gerona/glaf234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。